Le Lézard
Classified in: Health
Subjects: MAV, POL, MAT

Media Advisory - Sherwin Edwards from Vap Select to Participate in Sixth Estate Panel


ST. JANVIER, QC, Jan. 18, 2018 /CNW Telbec/ - Sherwin Edwards, Founder, President and CEO of Vap Select will join a cross section of experts who will discuss the merits of vaping as an alternative to cigarette smoke, to understand if vaping is really an option as a harm-reduction and life-saving alternative to tobacco products. The panel is organized by the Sixth Estate and will be moderated by Susan Delacourt.

Event: If Quitting Is Not An Option ... Is Vaping?
Information: https://sixthestate.ca/events/if-quitting-is-not-an-option-is-vaping/ 
When: January 23, 2018 
Where: Ottawa Marriott Hotel, 100 Kent Street
Program begins at 12:00 p.m. and finishes at 1:00 p.m.

Sherwin has taken a stand against the federal government's Bill S-5: An Act to amend the Tobacco Act and the Non-smokers' Health Act and to make consequential amendments to other Acts. His position is that Bill S-5 should not include vaping products by classifying them on the same shelf as tobacco products. He sponsored E-1237, an online e-petition, which calls for the suspension of Bill S-5 and for a distinction between tobacco and vaping products. The petition gathered 10,251 signatures while it remained online until the December 23, 2017 closing, making it one of the most successful online petitions submitted to the Canadian Parliament. Only 500 signatures are required for a petition to be read in the House of Commons. The petition gathered signatures from across Canada.

Sherwin is available for media interviews following the Sixth Estate panel discussion.

 

SOURCE Vap Select


These press releases may also interest you

at 22:03
The report titled "Carbon Dioxide Incubator Market by Product (Air Jacketed CO2 Incubators, Direct Heat CO2 Incubators, Water Jacketed CO2 Incubators), Capacity (100-200 Litre, Above 200 Litre, Below 100 Litre), Application, End User - Global...

at 22:00
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...

at 21:45
The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027 " report has been added to  ResearchAndMarkets.com's offering. Infectious disease Dx is...

at 21:30
The "Whole Genome and Exome Sequencing Markets by Application, Organism and Product with Executive and Consultant Guides. Includes Direct to Consumer Analysis. 2023 to 2027" report has been added to  ResearchAndMarkets.com's offering. Will all...

at 20:50
Pharma (1167.HK), a clinical-stage oncology company drugging the undruggable targets, today announced its 2023 annual results. The revenue was RMB63.5 million, the R&D investment was RMB372 million, the cash and cash equivalent at the end of 2023 was...

at 20:35
InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company announced that the first patient in China has been dosed in the Phase 1b clinical study of the combination of InnoCare's novel SHP2 (Src Homology 2 domain containing...



News published on and distributed by: